These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12054086)

  • 1. Chemokines in transplant rejection.
    Haskell CA; Ribeiro S; Horuk R
    Curr Opin Investig Drugs; 2002 Mar; 3(3):399-405. PubMed ID: 12054086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction.
    Merani S; Truong WW; Hancock W; Anderson CC; Shapiro AM
    Cell Transplant; 2006; 15(4):295-309. PubMed ID: 16898223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines and chronic heart allograft rejection.
    Smith RN; Ueno T; Ito T; Tanaka K; Shea SP; Abdi R
    Transplantation; 2007 Aug; 84(3):442-4. PubMed ID: 17700176
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemokines and chemokine receptors in glomerulonephritis and renal allograft rejection.
    Stasikowska O; Wagrowska-Danilewicz M
    Med Sci Monit; 2007 Feb; 13(2):RA31-6. PubMed ID: 17261994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines and chemokine receptors in renal transplantation--from bench to bedside.
    Fischereder M
    Acta Physiol Hung; 2007 Mar; 94(1-2):67-81. PubMed ID: 17444276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
    Vielhauer V; Anders HJ; Schlöndorff D
    Semin Nephrol; 2007 Jan; 27(1):81-97. PubMed ID: 17336691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines, their receptors, and transplant outcome.
    Colvin BL; Thomson AW
    Transplantation; 2002 Jul; 74(2):149-55. PubMed ID: 12151723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of chemokines and their receptors in ocular disease.
    Wallace GR; John Curnow S; Wloka K; Salmon M; Murray PI
    Prog Retin Eye Res; 2004 Jul; 23(4):435-48. PubMed ID: 15219876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving role of chemokines and their receptors in acute allograft rejection.
    Inston NG; Cockwell P
    Nephrol Dial Transplant; 2002 Aug; 17(8):1374-9. PubMed ID: 12147781
    [No Abstract]   [Full Text] [Related]  

  • 12. From basic science to clinical practice: use of cytokines and chemokines as therapeutic targets in renal diseases.
    Romagnani P
    J Nephrol; 2005; 18(3):229-33. PubMed ID: 16013008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CXCR3 and CCR5 in allograft rejection.
    Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
    Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine gene expression during allograft rejection: comparison of two quantitative PCR techniques.
    Carvalho-Gaspar M; Billing JS; Spriewald BM; Wood KJ
    J Immunol Methods; 2005 Jun; 301(1-2):41-52. PubMed ID: 16018884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomonitoring of renal transplant recipients in the early posttransplant period by sequential analysis of chemokine and chemokine receptor gene expression in peripheral blood mononuclear cells.
    Dalton RS; Webber JN; Pead P; Gibbs PJ; Sadek SA; Howell WM
    Transplant Proc; 2005 Mar; 37(2):747-51. PubMed ID: 15848520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances on the role of chemokines/chemokine receptors in the pathogenesis of idiopathic pulmonary fibrosis].
    Brunetti G; Pignatti P
    Recenti Prog Med; 2007 Feb; 98(2):90-6. PubMed ID: 17439069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine-directed strategies to attenuate allograft rejection.
    Schenk AD; Rosenblum JM; Fairchild RL
    Clin Lab Med; 2008 Sep; 28(3):441-54, vii. PubMed ID: 19028262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines and their receptors in allograft rejection.
    Hancock WW; Gao W; Faia KL; Csizmadia V
    Curr Opin Immunol; 2000 Oct; 12(5):511-6. PubMed ID: 11007352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine blockers--therapeutics in the making?
    Wells TN; Power CA; Shaw JP; Proudfoot AE
    Trends Pharmacol Sci; 2006 Jan; 27(1):41-7. PubMed ID: 16310864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.